A Study of BGB-A445 in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer Interventions: Drug: BGB-A445; Drug: Docetaxel; Drug: Tislelizumab; Drug: Sitravatinib; Drug: Ramucirumab; Drug: Selected Interventions; Drug: BGB-15025 Sponsor: BeiGene Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Docetaxel | Lung Cancer | Non-Small Cell Lung Cancer | Research | Study | Taxotere